GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Apures Co Ltd (XKRX:149300) » Definitions » Operating Margin %

Apures Co (XKRX:149300) Operating Margin % : -625.31% (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Apures Co Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Apures Co's Operating Income for the six months ended in Dec. 2023 was ₩-4,120.3 Mil. Apures Co's Revenue for the six months ended in Dec. 2023 was ₩658.9 Mil. Therefore, Apures Co's Operating Margin % for the quarter that ended in Dec. 2023 was -625.31%.

Good Sign:

Apures Co Ltd operating margin is expanding. Margin expansion is usually a good sign.

The historical rank and industry rank for Apures Co's Operating Margin % or its related term are showing as below:

XKRX:149300' s Operating Margin % Range Over the Past 10 Years
Min: -1219.76   Med: -613.48   Max: -73.8
Current: -625.31


XKRX:149300's Operating Margin % is ranked worse than
89.45% of 218 companies
in the Medical Diagnostics & Research industry
Industry Median: -5.795 vs XKRX:149300: -625.31

Apures Co's 5-Year Average Operating Margin % Growth Rate was 4.80% per year.

Apures Co's Operating Income for the six months ended in Dec. 2023 was ₩-4,120.3 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-4,120.3 Mil.

Warning Sign:

Apures Co Ltd has never been profitable in the past 3 years. It lost money every year.


Apures Co Operating Margin % Historical Data

The historical data trend for Apures Co's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apures Co Operating Margin % Chart

Apures Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -797.27 -1,219.76 -571.84 -543.43 -625.31

Apures Co Semi-Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only -797.27 -1,219.76 -571.84 -543.43 -625.31

Competitive Comparison of Apures Co's Operating Margin %

For the Diagnostics & Research subindustry, Apures Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apures Co's Operating Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Apures Co's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Apures Co's Operating Margin % falls into.



Apures Co Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Apures Co's Operating Margin % for the fiscal year that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=-4120.25 / 658.916
=-625.31 %

Apures Co's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=-4120.25 / 658.916
=-625.31 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Apures Co  (XKRX:149300) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Apures Co Operating Margin % Related Terms

Thank you for viewing the detailed overview of Apures Co's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Apures Co (XKRX:149300) Business Description

Traded in Other Exchanges
N/A
Address
44, Hansan-gil, Cheongbuk-eup, Gyeonggi-do, Pyeongtaek-si, KOR, 17792
Apures Co Ltd is a South Korea based company engaged in the development of transgenic animals to support bio heterogeneous long-term commercialization and new drug efficacy research. It has focused its research capabilities on developing transgenic mini pigs based on gene editing technology and somatic cell nuclear transfer technology.

Apures Co (XKRX:149300) Headlines

No Headlines